Literature DB >> 1536730

Diagnostic approaches to renal genetic disorders using DNA analysis.

C A Francomano1.   

Abstract

Recent developments in molecular genetic technology have made it possible to diagnose many genetic disorders affecting the kidney before they are clinically manifest. For a disorder to be diagnosed by DNA analysis, either the causative gene must be known and cloned, or a closely linked DNA segment must have been identified. If one of these criteria is met, the disorder may be diagnosed either by direct detection of a mutation, if it is known, or indirectly by linkage analysis of the region using closely linked genetic markers. The methodology currently employed for direct detection of mutation includes the Southern blot, which will detect large structural alterations of genes or mutations altering a restriction recognition site, or the use of allele-specific oligonucleotides, which will detect specific point mutations. Linkage analysis is performed on DNA from multiple family members of the person at risk. Polymorphic markers are "tracked" in the family to determine the allele segregating with the disease gene. These methods are now routinely applied to the diagnosis of mendelian disorders affecting the kidney. It is anticipated that progress over the next decade will extend these applications to detection of the genetic component(s) contributing to multifactorial conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536730     DOI: 10.1007/bf00856854

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  36 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Analysis of WAGR deletions and related translocations with gene-specific DNA probes, using FACS-selected cell hybrids.

Authors:  A Seawright; J M Fletcher; J A Fantes; H Morrison; D J Porteous; S S Li; N D Hastie; V Van Heyningen
Journal:  Somat Cell Mol Genet       Date:  1988-01

Review 3.  Molecular genetics of the fourth component of human complement and steroid 21-hydroxylase.

Authors:  M C Carroll; K T Belt; A Palsdottir; Y Yu
Journal:  Immunol Rev       Date:  1985-10       Impact factor: 12.988

Review 4.  Report of the committee on clinical disorders and chromosomal deletion syndromes.

Authors:  P S Harper; J Frézal; M A Ferguson-Smith; A Schinzel
Journal:  Cytogenet Cell Genet       Date:  1989

Review 5.  The morbid anatomy of the human genome: a review of gene mapping in clinical medicine (2).

Authors:  V A McKusick
Journal:  Medicine (Baltimore)       Date:  1987-01       Impact factor: 1.889

6.  Detection of single base substitutions in total genomic DNA.

Authors:  R M Myers; N Lumelsky; L S Lerman; T Maniatis
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

Review 7.  DNA polymorphism and molecular pathology of the human globin gene clusters.

Authors:  S E Antonarakis; H H Kazazian; S H Orkin
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

Review 10.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.